Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Oct 18, 2023
Company Ranks Top 2 in Healthcare Equipment and Services Industry FRANKLIN LAKES, N.J., Oct. 18, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...
-
Oct 17, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Greg Rodetis, currently BD senior vice president and treasurer will also add head of...
-
Oct 16, 2023
All Used Injection Devices Recycled; Next Stage of Pilot to Expand Regionally, Add Medical Devices FRANKLIN LAKES, N.J. and RUTLAND, Vt., Oct. 16, 2023 /PRNewswire/ -- BD (Becton, Dickinson and...
-
Oct 12, 2023
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it will report its fiscal 2023 fourth quarter and full year financial results on...
-
Oct 1, 2023
FRANKLIN LAKES, N.J. (Oct. 1, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced Bridget Bagnato has been named president of BD...
-
Sep 19, 2023
Recognition underscores company's commitment to transparency and values FRANKLIN LAKES, N.J., Sept. 19, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...
-
Aug 23, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo...
-
Aug 10, 2023
First patient enrollment in ARCH study begins investigation of the safety and effectiveness of the BD Liverty™ Transjugular Intrahepatic Portosystemic Shunt (TIPS) Stent Graft to reduce...
-
Aug 3, 2023
Increased manufacturing capacity combined with an expansion from 69 to 92 eligible countries, is expected to enable delivery of more than 320 million doses through 2030 Previously guaranteed...
-
Aug 3, 2023
Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™ Infusion System Revenue of $4.9 billion...
-
Aug 1, 2023
Single Test on BD MAX™ System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and...
-
Jul 25, 2023
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.91 per common share, payable on September 29, 2023 to holders of record on...
-
Jul 25, 2023
Reflects Commitment to Gender Equality and Progress in Advancing ESG Strategy FRANKLIN LAKES, N.J. (July 25, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...
-
Jul 24, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher,...
-
Jul 24, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX) Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration (FDA) 510(k) clearance for the...
-
Jul 21, 2023
BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA)...
-
Jul 20, 2023
Company Expands its ESG Focus Areas to Include Advancing Health Equity in Under-Resourced Communities FRANKLIN LAKES, N.J., July 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:...
-
Jul 13, 2023
FRANKLIN LAKES, N.J. (July 13, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it is one of 200 companies named to U.S....
-
Jul 11, 2023
Top Score on Disability Equality Index Demonstrates Ongoing Progress in Creating Employment Opportunities for People with Disabilities FRANKLIN LAKES, N.J., July 11, 2023 /PRNewswire/ -- BD...
-
Jul 6, 2023
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its third quarter of fiscal year 2023 on...
-
Jun 22, 2023
FRANKLIN LAKES, N.J. (June 22, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Brooke Story has been named president of...
-
Jun 20, 2023
Divestiture Advances BD2025 Strategy to Simplify Portfolio and Focus on Higher-Growth Markets FRANKLIN LAKES, N.J., June 20, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a...
-
Jun 12, 2023
BD FACSDuet™ Premium System Leverages Robotics to Automate Sample Preparation for Greater Standardization in Clinical Flow Cytometry Diagnostics FRANKLIN LAKES, N.J., June 12, 2023 /PRNewswire/...
-
Jun 12, 2023
Awards and new survey findings represent important milestones on non-profit healthcare consortium’s path to changing expectations around resiliency The following press release was issued by the...
-
Jun 2, 2023New Investments by BD to Add More Than 85 New Jobs in Ireland
DUBLIN (2 June 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today held a grand opening ceremony for a new €4 million research and...